Enfermedad de CROHN metastásica: respuesta a intensificación de tratamiento con adalimumab

We report the case of a female patient with longstanding and complex Crohn's disease who developed metastatic cutaneous manifestations while receiving adalimumab. The cutaneous manifestations responded well to dose intensification of this drug. A review of the literature is provided.